|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
PALBOCICLIB |
L01EF01 |
IT
|
I
|
05-01-2021 |
EMEA/H/C/003853 |
09-11-2016 |
VALID
|
|
PANOBINOSTAT |
L01XH03 |
IT
|
I
|
05-01-2021 |
EMEA/H/C/003725 |
28-08-2015 |
VALID
|
|
TISAGENLECLEUCEL |
L01XL04 |
IT
|
I
|
05-01-2021 |
|
|
VALID
|
|
SONIDEGIB |
L01XJ02 |
IT
|
I
|
06-01-2021 |
EMEA/H/C/002839 |
14-08-2015 |
VALID
|
|
AMIKACIN |
J01GB06 |
IT
|
II
|
18-01-2021 |
|
11-02-2002 |
VALID
|
|
MIDAZOLAM |
N05CD08 |
IT
|
I
|
25-01-2021 |
|
|
VALID
|
|
LARONIDASE |
A16AB05 |
IT
|
I
|
26-01-2021 |
|
|
VALID
|
|
CODEINE, COMBINATIONS EXCL. PSYCHOLEPTICS |
N02AA59 |
IT
|
Not authorised
|
03-02-2021 |
|
|
VALID
|
|
DEXLANSOPRAZOLE |
A02BC06 |
IT
|
Not authorised
|
03-02-2021 |
|
|
VALID
|
|
LEVONORGESTREL |
G03AD01 |
IT
|
Not subject to prescription
|
03-02-2021 |
|
|
VALID
|
|
SOMATROPIN |
H01AC01 |
IT
|
II
|
03-02-2021 |
IT/H/0025/006/ |
07-11-2014 |
VALID
|
|
ACALABRUTINIB |
L01EL02 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005299 |
05-11-2020 |
VALID
|
|
AVAPRITINIB |
L01EX18 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005208 |
24-09-2020 |
VALID
|
|
BENZOCAINE |
D04AB04 |
IT
|
Not subject to prescription
|
03-03-2021 |
|
22-08-2003 |
VALID
|
|
BIOTIN |
A11HA05 |
IT
|
Not subject to prescription
|
03-03-2021 |
|
22-08-2003 |
VALID
|
|
BUPIVACAINE AND MELOXICAM |
N01BB59 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005205 |
24-09-2020 |
VALID
|
|
CABOTEGRAVIR |
J05AJ04 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/004976 |
17-12-2020 |
VALID
|
|
CLEMASTINE |
D04AA14 |
IT
|
Not authorised
|
03-03-2021 |
|
22-08-2003 |
VALID
|
|
COVID-19 VACCINES |
J07BX03 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005735 |
21-12-2020 |
VALID
|
|
CRIZANLIZUMAB |
B06AX01 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/004874 |
28-10-2020 |
VALID
|
|
DIPHENHYDRAMINE |
D04AA32 |
IT
|
Not subject to prescription
|
03-03-2021 |
|
22-08-2003 |
VALID
|
|
FAT EMULSIONS |
B05BA02 |
IT
|
I
|
03-03-2021 |
|
|
VALID
|
|
FILGOTINIB |
L04AF04 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005113 |
24-09-2020 |
VALID
|
|
FORMOTEROL, GLYCOPYRRONIUM BROMIDE AND BUDESONIDE |
R03AL11 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/004983 |
09-12-2020 |
VALID
|
|
ISOTHIPENDYL |
D04AA22 |
IT
|
Not authorised
|
03-03-2021 |
|
|
VALID
|
|
LUMASIRAN |
A16AX18 |
IT
|
I
|
03-03-2021 |
|
|
VALID
|
|
OBILTOXAXIMAB |
J06BC04 |
IT
|
I
|
03-03-2021 |
EMEA/H/C/005169 |
18-11-2020 |
VALID
|
|
OXYBUPROCAINE |
D04AB03 |
IT
|
Not authorised
|
03-03-2021 |
|
|
VALID
|
|
PERINDOPRIL AND AMLODIPINE |
C09BB04 |
IT
|
II
|
03-03-2021 |
IT/H/0374/002/ |
19-03-2015 |
VALID
|
|
PERINDOPRIL AND DIURETICS |
C09BA04 |
IT
|
II
|
03-03-2021 |
|
|
VALID
|
|
PERINDOPRIL, AMLODIPINE AND INDAPAMIDE |
C09BX01 |
IT
|
II
|
03-03-2021 |
|
15-07-2014 |
VALID
|
|
PRAMOCAINE |
D04AB07 |
IT
|
Not authorised
|
03-03-2021 |
|
|
VALID
|
|
PROMETHAZINE |
D04AA10 |
IT
|
Not subject to prescription
|
03-03-2021 |
|
22-08-2003 |
VALID
|
|
ROSUVASTATIN, PERINDOPRIL AND INDAPAMIDE |
C10BX13 |
IT
|
Not authorised
|
03-03-2021 |
|
|
VALID
|
|
THONZYLAMINE |
D04AA01 |
IT
|
Not authorised
|
03-03-2021 |
|
|
VALID
|
|
FLUDEOXYGLUCOSE (18F) |
V09IX04 |
IT
|
I
|
05-03-2021 |
|
|
VALID
|
|
FLUORODOPA (18F) |
V09IX05 |
IT
|
I
|
05-03-2021 |
|
|
VALID
|
|
GALLIUM (68GA) EDOTREOTIDE |
V09IX09 |
IT
|
I
|
05-03-2021 |
|
|
VALID
|
|
IBRITUMOMAB TIUXETAN (90Y) |
V10XX02 |
IT
|
I
|
05-03-2021 |
|
|
VALID
|
|
INOTERSEN |
N07XX15 |
IT
|
I
|
05-03-2021 |
|
|
VALID
|
|
ROMOSOZUMAB |
M05BX06 |
IT
|
I
|
05-03-2021 |
|
|
VALID
|
|
AMIODARONE |
C01BD01 |
IT
|
II
|
01-06-2021 |
|
|
VALID
|
|
ARIPIPRAZOLE |
N05AX12 |
IT
|
II
|
01-06-2021 |
|
|
VALID
|
|
BOCEPREVIR |
J05AP03 |
IT
|
Not authorised
|
01-06-2021 |
|
|
VALID
|
|
CENOBAMATE |
N03AX25 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005377 |
26-03-2021 |
VALID
|
|
FEDRATINIB |
L01XE57 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005026 |
08-02-2021 |
VALID
|
|
FOSTEMSAVIR |
J05AX29 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005011 |
04-02-2021 |
VALID
|
|
MOXETUMOMAB PASUDOTOX |
L01FB02 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005322 |
08-02-2021 |
VALID
|
|
OFATUMUMAB |
L04AG12 |
IT
|
Not authorised
|
01-06-2021 |
|
|
VALID
|
|
REMIMAZOLAM |
N05CD14 |
IT
|
I
|
01-06-2021 |
EMEA/H/C/005246 |
26-03-2021 |
VALID
|
